Tumor segmentation software receives 510k clearance from FDA

9 octubre 2014

New imaging software that facilitates 3-D lung tumor segmentation has been incorporated into the Smart Segmentation® module of Varian’s Eclipse™ treatment planning system and has received FDA 510k clearance.
http://feeds.sciencedaily.com/~r/sciencedaily/~3/jlO5Xs6Q2VQ/141009141500.htm